Get started
Author

Maryam Shah

Observed name: M. Shah
OpenAlex ID: A5113949258
Paediatric specific dosage forms: Patient and formulation considerations
2022 · Dilawar Khan, Daniel Kirby, et al. · International Journal of Pharmaceutics · 120
PDF
Commentary: New perspectives on protein aggregation during Biopharmaceutical development
2018 · Maryam Shah · International Journal of Pharmaceutics · 29
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
2019 · Shraddha S. Rane, Rebecca J. Dearman, et al. · Pharmaceutical Research · 24
PDF
Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range
2017 · Maryam Shah, Zahra Rattray, et al. · International Journal of Pharmaceutics · 18
PDF
Micro- and macro-viscosity relations in high concentration antibody solutions
2020 · M. Shah, D. Corbett, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 17
Cluster Percolation Causes Shear Thinning Behavior in Concentrated Solutions of Monoclonal Antibodies
2021 · Alfredo Lanzaro, Aisling Roche, et al. · Molecular Pharmaceutics · 15
Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
2021 · Dilawar Khan, Daniel Kirby, et al. · Pharmaceutics · 13
PDF
Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use
2023 · Dilawar Khan, Raj Badhan, et al. · Pharmaceutics · 3
PDF
P23 Accelerating and de-risking the production of paediatric oral formulations
2020 · Dilawar Khan, Daniel Kirby, et al. · Archives of Disease in Childhood
PDF
Quantitative analysis of monoclonal antibody formulations using image and fluorescence correlation spectroscopies
2018 · Maryam Shah · Research Explorer (The University of Manchester)
Works count: 10
Citation count: 239
H-index: 7
I10-index: 7
Year
Topic
Type